195 related articles for article (PubMed ID: 6971636)
41. [Cancer metastasis and immunology].
Ba DN
Zhonghua Zhong Liu Za Zhi; 1984 Mar; 6(2):154-6. PubMed ID: 6331999
[No Abstract] [Full Text] [Related]
42. Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice.
Radzikowski C; Rygaard J; Budzynski W; Stenvang JP; Schou M; Vangsted A; Zeuthen J
APMIS; 1994 Jul; 102(7):481-8. PubMed ID: 7917216
[TBL] [Abstract][Full Text] [Related]
43. Possible role of natural killer cells and other effector cells in immune surveillance against cancer.
Herberman RB
J Invest Dermatol; 1984 Jul; 83(1 Suppl):137s-140s. PubMed ID: 6376648
[TBL] [Abstract][Full Text] [Related]
44. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
[TBL] [Abstract][Full Text] [Related]
45. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
46. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
[TBL] [Abstract][Full Text] [Related]
47. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
[TBL] [Abstract][Full Text] [Related]
48. Clonogenic and functional potential of T lymphocytes infiltrating human solid tumors.
von Fliedner V; Qiao L; Whiteside TL; Leyvraz S; Barras C; Miescher S
Prog Clin Biol Res; 1987; 244():223-32. PubMed ID: 3498950
[No Abstract] [Full Text] [Related]
49. Central issues in present-day tumor immunology: interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor-reactive lymphocytes in patients.
Klein E
Transplant Proc; 1981 Mar; 13(1 Pt 2):723-8. PubMed ID: 6168071
[No Abstract] [Full Text] [Related]
50. Immunological defence mechanisms of the gastrointestinal tract.
Jewell DP
Neth J Med; 1984; 27(7):242-8. PubMed ID: 6387517
[No Abstract] [Full Text] [Related]
51. Natural killer cells--immunologist's fancy?
Gupta S
Gastroenterology; 1980 Apr; 78(4):865-7. PubMed ID: 6965484
[No Abstract] [Full Text] [Related]
52. [Immunomodulating properties of interferons].
Korobkov SV
Tr Inst Im Pastera; 1985; 62():101-4. PubMed ID: 2438812
[No Abstract] [Full Text] [Related]
53. Regulation of immune functions in the fetus and newborn.
Murgita RA; Wigzell H
Prog Allergy; 1981; 29():54-133. PubMed ID: 6460251
[No Abstract] [Full Text] [Related]
54. [Subpopulations of human T-lymphocytes and their suppressor functions].
Brondz BD
Ter Arkh; 1980; 52(9):120-32. PubMed ID: 6449090
[No Abstract] [Full Text] [Related]
55. [Immunology of tumors of the central nervous system].
de Micco C
Bull Cancer; 1989; 76(1):17-31. PubMed ID: 2653471
[TBL] [Abstract][Full Text] [Related]
56. [Principles of clinical immunology. II. Lymphocytes and the development of immunological reaction].
Kuratowska Z
Pol Tyg Lek; 1978 May; 33(19):779-82. PubMed ID: 307241
[No Abstract] [Full Text] [Related]
57. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
Talmadge JE; Herberman RB
Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
[No Abstract] [Full Text] [Related]
58. [Antitumor activities in the aspects of evolution and development].
Muramatsu S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):720-5. PubMed ID: 3872630
[TBL] [Abstract][Full Text] [Related]
59. [Bio-defense-expression in the protection against microbial infections].
Nomoto K
Kekkaku; 1987 Jan; 62(1):1-10. PubMed ID: 3553695
[No Abstract] [Full Text] [Related]
60. [Possible approaches to the study of the immunological status of cancer patients and healthy people].
Montsevichiute-Eringene EV
Eksp Onkol; 1984; 6(2):8-14. PubMed ID: 6391906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
